DEUTSCHE BANK AG\

Bank

Position in NAMS — NewAmsterdam Pharma Co N.V.

CIK 948046 FRANKFURT AM MAIN, 2M

Position in NAMS

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$6,775,660

+$2,781,613 QoQ

Shares Held

199,931

+60.2% QoQ

Ownership

0.167%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#58

of 197 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 98% Shared 0% None 2%

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. NAMS ranks #53 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,579,110	$784,391,303
2	REGN	Regeneron Pharmaceuticals, Inc.	518,409	$323,248,743
3	ALNY	Alnylam Pharmaceuticals, Inc.	815,400	$245,459,858
4	RVMD	Revolution Medicines, Inc.	888,019	$166,308,196
5	RPRX	Royalty Pharma plc	2,717,951	$152,395,510
6	INCY	Incyte Corp	1,262,988	$143,172,312
7	ARGX	Argenx SE	137,335	$127,415,291
8	LGND	Ligand Pharmaceuticals Inc	249,611	$78,899,539

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,775,660	199,931	+60.2%	Shares	Defined	2026-08-07
2026-03-31	$3,994,047	124,775	+0.7%	Shares	Defined	2026-05-06
2025-12-31	$4,348,622	123,963	+81.2%	Shares	Defined	2026-02-11
2025-09-30	$1,946,007	68,425	+0.5%	Shares	Defined	2025-11-13
2025-06-30	$1,233,146	68,092	-5.9%	Shares	Defined	2025-08-12
2025-03-31	$1,481,965	72,397	+2634.0%	Shares	Defined	2025-05-09
2024-12-31	$68,053	2,648	+8.1%	Shares	Defined	2025-06-30
2024-09-30	$40,653	2,449	—	Shares	Defined	2025-06-26
No filing history on record for this holder in this stock.